Veliparib
| Veliparib | |
|---|---|
| Term | Veliparib |
| Short definition | veliparib - (pronounced) (veh-lih-PAR-ib) substance being studied to treat breast cancer caused by mutations (changes) in the BRCA1 and BRCA2 genes. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
veliparib - (pronounced) (veh-lih-PAR-ib) substance being studied to treat breast cancer caused by mutations (changes) in the BRCA1 and BRCA2 genes. It is also being studied in the treatment of other types of cancer. It blocks an enzyme involved in many cell functions, including repairing DNA damage. DNA damage can be caused by normal cell action, UV light, some cancer drugs, and radiation used to treat cancer. Veliparib can cause cancer cells to die. It is a type of poly(ADP-ribose) polymerase inhibitor. Also called ABT-888 and PARP-1 inhibitor ABT-888
External links
- Medical encyclopedia article on Veliparib
- Wikipedia's article - Veliparib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski